Stoke Corp (STOK) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Stoke Therapeutics (STOK) narxlarining trayektoriyasi noyob miya patologiyalari uchun RNK-dori ishlab chiquvchining dinamikasini aks ettiradi, uning noyob TANGO platformasi esa xususiy metodologiyani ta'minlaydi. Joriy ko'rsatkich 0.00 ni tashkil etadi. Gen terapiyasining istiqbollariga qaramay, Stoke Therapeutics (STOK) jiddiy ilmiy qiyinchiliklar va muqobil davolash usullari tomonidan bosimga duch kelmoqda. Biznes kapitalizatsiyasi klinik sinovlarning muvaffaqiyatiga bog'liq bo'lib, bu uni umumiy iqtisodiy sikllardan mustaqil qiladi.
Stoke Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Jamlagan qarzning kapitalga nisbati Stoke Therapeutics|STOK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati stoketherapeutics.com|STOK - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Stoke Therapeutics, Inc.|STOK - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Stoke Therapeutics|Oraliq qoplash koeffitsiyenti stoketherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:STOK, Stoke Therapeutics Inc
Biznes qiymati makrotsikllardan ko'ra klinik sinovlarning muvaffaqiyati bilan belgilanadigan Stoke Therapeutics (STOK) biotexnologiya sektori uchun ushbu ko'rsatkich moliyaviy barqarorlikning o'lchovi bo'lib xizmat qiladi. Muddati bir yildan ortiq bo'lgan majburiyatlarni kapital bilan solishtirish orqali, uzoq muddatli qarzdorlikning kapitalga nisbati investorlarga qarz yukining darajasini va kompaniyaning kritik leverajsiz innovatsiyalarni moliyalashtirish qobiliyatini baholash imkonini beradi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati GeneDx Holdings WGS|RARE (Ultragenyx Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BEAM: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati twistbioscience.com TWST|Uzoq muddatli qarzning o'z kapitaliga nisbati 10x Genomics (TXG)|Uzoq muddatli qarzning kapitalga nisbati Intellia Therapeutics Inc (NTLA)|Uzoq muddatli qarzning kapitalga nisbati BLFS (BioLife Corp)|Wave Pharma (WVE) - Uzoq muddatli majburiyatlarning kapitalga nisbati|MAZE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SION (sionnatx.com)|PRME (Prime Medicine) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TSHA: Uzoq muddatli kreditlarning kapitalga nisbati|QURE (uniQure Corp) - Uzoq muddatli qarzning kapitalga nisbati|MGTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati RGNX|SLDB - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Ocugen OCGN|Uzoq muddatli qarzning kapitalga koeffitsiyenti PACB|Benitec - Uzoq muddatli qarzning kapitalga nisbati|DSGN - Uzoq muddatli qarzning kapitalga nisbati|Rocket Pharmaceuticals (RCKT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati FDMT (4dmoleculartherapeutics.com)|LXEO (Lexeo Therapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Korro Bio, Inc KRRO|Uzoq muddatli qarzning o'z kapitaliga nisbati EDIT (Editas)|Uzoq muddatli qarzning kapitalga nisbati Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati CDXS (Codexis Inc)|Sangamo Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Nautilus Biotechnology NAUT|MGX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Precision BioSciences Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Generation Bio Co|boundlessbio.com (BOLD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzdorlikning kapitalga nisbati imunon.com|Phio Pharmaceuticals Corp. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati MBIO (Mustang Bio Inc)|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Bionano Genomics, Inc.|Applied DNA Sciences, Inc. (APDN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|bluebird bio Inc. (BLUE) - Uzoq muddatli qarzning kapitalga nisbati|IPA (ImmunoPrecise Antibodies Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Unity Biotechnology, Inc UBX